Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Oct;44(4):561–566. doi: 10.1038/bjc.1981.226

Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in rat.

H Barbason, E H Betz
PMCID: PMC2010815  PMID: 7295512

Abstract

Diethylnitrosamine (DEN, 10 mg/kg/day) was fed to rats for 2, 4 and 6 weeks. At different times after feeding with DEN was stopped, growth of preneoplastic lesions has been correlated with pathological evolution (preneoplastic foci, neoplastic nodules and hepatomas). The proliferating fraction in the foci, the cell content, and relative volume of foci increase as a function of the duration of the treatment. The proliferating fraction increases evenly throughout the liver, but, in all experimental modalities, preneoplastic cells show a proliferative advantage over the phenotypically normal tissue. In each experimental group, the proliferative rate correlates with the pathological evolution. After 2 weeks of DEN feeding the growth activity of foci remains very low, and neoplastic nodules are not detectable until the median time of death (14 months). After 4 and 6 weeks, a critical size of the foci is reached, corresponding to the neoplastic transformation, and an increased labelling index is triggered in the lesions and in the phenotypically normal tissue. It is speculated that the "growth pressure" induced by the first carcinogen treatment, associated with the subsequent disturbance of the mitotic control regulation, may be implicated in the process of malignant transformation of preneoplastic lesions.

Full text

PDF
561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbason H., Betz E. H. Liver cell control after discontinuation of DENA feeding in hepatocarcinogenesis. Eur J Cancer. 1981 Feb;17(2):149–154. doi: 10.1016/0014-2964(81)90029-3. [DOI] [PubMed] [Google Scholar]
  2. Barbason H., Fridman-Manduzio A., Betz E. H. Long term effects of a single dose of dimethylnitrosamine on the rat liver. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975 Oct 27;84(2):135–142. doi: 10.1007/BF00304039. [DOI] [PubMed] [Google Scholar]
  3. Barbason H., Fridman-Manduzio A., Lelievre P., Betz E. H. Variations of liver cell control during diethylnitrosamine carcinogenesis. Eur J Cancer. 1977 Jan;13(1):13–18. doi: 10.1016/0014-2964(77)90223-7. [DOI] [PubMed] [Google Scholar]
  4. Farber E., Parker S., Gruenstein M. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res. 1976 Nov;36(11 Pt 1):3879–3887. [PubMed] [Google Scholar]
  5. Rabes H. M., Scholze P., Jantsch B. Growth kinetics of diethylnitrosamine-induced, enzyme-deficient "preneoplastic" liver cell populations in vivo and in vitro. Cancer Res. 1972 Nov;32(11):2577–2586. [PubMed] [Google Scholar]
  6. Rabes H. M., Szymkowiak R. Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis. Cancer Res. 1979 Apr;39(4):1298–1304. [PubMed] [Google Scholar]
  7. Rabes H., Hartenstein R., Scholze P. Specific stages of cellular response to homeostatic control during diethylnitrosamine-induced liver carcinogenesis. Experientia. 1970 Dec 15;26(12):1356–1359. doi: 10.1007/BF02113030. [DOI] [PubMed] [Google Scholar]
  8. Squire R. A., Levitt M. H. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 1975 Nov;35(11 Pt 1):3214–3223. [PubMed] [Google Scholar]
  9. Weibel E. R. An automatic sampling stage microscope for stereology. J Microsc. 1970 Feb;91(1):1–18. doi: 10.1111/j.1365-2818.1970.tb02199.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES